Lobular breast cancer: Same survival and local control compared with ductal cancer, but should both be treated the same way? Analysis of an institutional database over a 10-year period

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1107-1114

  Fortunato, Lucio ^a   Mascaro, Alessandra ^a   Poccia, Igor ^a   Andrich, Renato ^a   Amini, Mostafà ^a   Costarelli, Leopoldo ^a   Cortese, Giuliana ^b   Farina, Massimo ^a   Vitelli, Carlo ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; INVASIVE DUCTAL CANCER; INVASIVE LUNG CARCINOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84862488033     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1907-9     Document Type: Article

References (58)

1. Foote FW Jr, Stewart FW. A histologic classification of carcinoma of the breast. Surgery. 1946;19:74-99.
2. Bouvet M, Ollila DW, Hunt KK et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:650-54. (Pubitemid 127725494)
3. Orvieto E, Maiorano E, Bottiglieri L et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast. Cancer. 2008;113:1511-20.
4. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545-50. (Pubitemid 127725500)
5. Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. Infiltrating lobular carcinoma - a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. The Breast. 2004;13:389-96. (Pubitemid 39549788)
6. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-20. (Pubitemid 26002745)
7. Mallon E, Varga Z: relapse of invasive lobular carcinoma. Breast Dis. 2009;30:53-6.
8. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical out-come. Breast Cancer Res. 2004;6:R149-56.
9. McGuire KP, Santillan AA, Kaur P. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682-90.
10. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-32. (Pubitemid 35176241)
11. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98:697-702. (Pubitemid 36959264)
12. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of breast: presentation, treatment, and outcomes. JACS. 1998;186:416-22. (Pubitemid 28169363)
13. Salvadori B, Biganzoli E, Veronesi P, et al. Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg. 1997;84:106-9. (Pubitemid 27033122)
14. Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE. Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol. 1997;4:198-202. (Pubitemid 127725244)
15. Peiro G, Bornstein BA, Connolly JL. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000;59:49-54. (Pubitemid 30153897)
16. Mersin H, Yildrim E, Gulben K, Berberoglu U: Is invasive lobular carcinoma different from invasive ductal carcinoma? EJSO. 2003;29:390-5. (Pubitemid 36675699)
17. Santiago RJ, Harris EER, Qin L. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast. Cancer. 2005;103:2447-54. (Pubitemid 40800521)
18. Vo TN, Meric-Bernstam F, Yi M, et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg. 2006;192:552-5. (Pubitemid 44344191)
19. Fritz P, Klenk S, Goletz S, et al. Clinical impacts of histological subtyping primary breast cancer. Anticancer Res. 2010;30:5137-44.
20. Fortunato L, Mascaro A, Amini M, Farina M, Vitelli CE. Sentinel lymph node biopsy in breast cancer. Surg Oncol Clin North Am. 2008;17:673-99. (Pubitemid 351672074)
21. Mann RM. The effectiveness of MR Imaging in the assessment of invasive lobular carcinoma of the breast. Magn Reson Imaging Clin North Am. 2010;18:259-76.
22. Furman B, Gardner MS, Romilly P, et al. Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. Am J Surg. 2003;186:344-7. (Pubitemid 38368607)
23. Brem RF, Ioffe M, Rapelyea JA, Yost KG, Weigert JM, Bertrand ML, Stern LH. Invasive lobular carcinoma; detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR. 2009;192:379-83.
24. Siegmann KC, Baur A, Vogel U, Kraemer B, Hahn M, Claussen CD. Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer. Clin Radiol. 2009;64:403-13.
25. Wagner PL, Kitabayashi N, Chen YT, Shin SJ. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast. A molecular study of 10 cases. Am J Clin Pathol. 2009;132:871-6.
26. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenina in invasive lobular breast canceer and lobular carcinoma in situ. J Pathol. 1997; 183:404-11. (Pubitemid 27509246)
27. Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic path-ways in ductal and lobular breast cancer? Breast Cancer Res. 2002;4:5-8.
28. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36:1-85.
29. Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 2000;88:2561-69. (Pubitemid 30331964)
30. Choi YJ, Pinto MM, Hao L, Riba AK. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol. 2008;21:1224-37. Epub 2008 Jun 27.
31. Longacre TA, Ennis M, Quennevill LA, et al. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol. 2006;19:195-207. (Pubitemid 43117604)
32. Wasif N, Maggard MA, Ko CY, Giuliano AE. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of out-comes. Ann Surg Oncol. 2010;17:1862-9.
33. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson Ed, Colburn WJ, Senofsky GM, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673-7. (Pubitemid 24085268)
34. Ashikari R, Huvos AG, Urban JA, Robbins GF. Infiltrating lobular carcinoma of the breast. Cancer. 1973;31:110-6.
35. Lesser M, Rosen PP, Kinne D. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982;91:234-40. (Pubitemid 12168596)
36. Horn PL, Thompson WD. Risk of contralateral breast cancer: association with histologic, clinical, and therapeutic factors. Cancer. 1988;62:412-24.
37. Du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW. Invasive lobular carcinomas of the breast - the prognosis of histopathological subtypes. Br J Cancer. 1989;60:605-9. (Pubitemid 19251460)
38. Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer. 1986;58:1995-2002. (Pubitemid 16008774)
39. Hussien M, Lioe TF, Finnegan J, Spence RA. Surgical treatment for invasive lobular carcinoma of the breast. Breast. 2003;12:23-35. (Pubitemid 36395483)
40. Viale G, Rotmensz N, Maisonneuve P, et al. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat. 2009;117:211-4.
41. Singletary SE, Patel-Parekh L, Bland KI: Treatment trends in errly-stage invasive lobular carcinoma; A report from the National Cancer Data Base. Ann Surg. 2005;242:281-9. (Pubitemid 41033446)
42. Gentilini O, Botteri E, Rotmensz N, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat. 2009;113:577-83. Epub 2008 Mar 11.
43. Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691-6. Epub 2009 Jun 9.
44. Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697-704.
45. Schnitt SJ, Connolly JL, Recht A, Silver B, Harrir JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 1989;64:448-54. (Pubitemid 19180408)
46. White JR, Gustafson GS, Wimbish K, et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer. 1994;74:640-7.
47. Weiss MC, Fowble BL, Solin LJ, Yeh IT, Schultz DL. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23:941-7.
48. Poen JC, Tran L, Juillard G, et al. Conservation therapy for invasive lobular carcinoma of the breast. Cancer. 1992;69:2789-95.
49. Santiago RJ, Wu L, Harris E, Fox J, Schultz D, Glick J, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2004;58:233-40. (Pubitemid 38010357)
50. Haffty BG, Goldberg NB, Rose M, et al. Conservative surgery with radiation therapy in clinical Stage I and II breast cancer. Results of a 20-year experience. Arch Surg. 1989;124:1266-1270. (Pubitemid 19275033)
51. Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245-51.
52. Mansfield CM, Komarnicky LT, Schwartz GF, et al. Ten-year results in 1070 patients with Stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer. 1995;75:2328-36.
53. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-year results after sector resection with or without postoperative radiotherapy for Stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326-33. (Pubitemid 29368230)
54. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med. 2003;163:2149-53. (Pubitemid 37248779)
55. Allemani C, Sant M, Berrino F, et al. Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study. Br J Cancer. 2004;91:1263-8. (Pubitemid 39424785)
56. du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JG, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251-7.
57. Mhuircheartaigh JN, Curran C, Hennessy E, Kerin MJ. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma. Br J Surg. 2008;95:827-33.
58. Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J. 2007;13:479-85. (Pubitemid 47329335)